Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

84.95
0.0000
Volume:- -
Turnover:- -
Market Cap:9.01B
PE:-16.89
High:84.95
Open:84.95
Low:84.95
Close:84.95
52wk High:85.01
52wk Low:31.00
Shares:106.10M
Float Shares:95.53M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0290
EPS(LYR):-4.9500
ROE:-42.45%
ROA:-26.28%
PB:7.56
PE(LYR):-17.16

Loading ...

Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities